Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

ICAM-1 in Acute Myocardial Infarction: A Potential Therapeutic Target

Author(s): Victoria Benson, Aisling Clare McMahon and Harry Claude Lowe

Volume 7, Issue 2, 2007

Page: [219 - 227] Pages: 9

DOI: 10.2174/156652407780059131

Price: $65

Abstract

Current treatments for AMI centre on prompt restoration of epicardial coronary blood flow. Despite improvements, AMI is still associated with significant morbidity and mortality. Novel approaches are therefore keenly sought. Intercellular adhesion molecule-1 (ICAM-1, CD54) is a member of the immunoglobulin superfamily. It is implicated in neutrophil and monocyte-endothelial cell adhesion, processes contributing to myocardial neutrophil infiltration and microvascular coronary slow flow, both viewed as important to the pathophysiologic responses in AMI. ICAM-1 would therefore appear an important potential therapeutic target in this context, and is the subject of this review.

Keywords: Acute myocardial infarction, ischaemia, reperfusion, adhesion molecule

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy